The SURMOUNT program (NEJM 2022) studied tirzepatide for weight management, and SURMOUNT-OSA (NEJM 2024) examined it for obstructive sleep apnea
Pike AL, Horwitz DF, Lobprise H
Pharmacy-compounded alternative for patients when brand medication is not available or covered
It is appropriate for both men and women and can be integrated alongside other peptide or weight loss protocols
What they are, how they work, and what medications are FDA-approved today In recent years, weight loss medications, especially GLP-1 receptor agonists , have gained popularity
Semaglutide can be effective for weight loss, but some people may experience side effects as their body adjusts